Tocagen (TOCA:NASDAQ) Investor Relations Material

Overview

Tocagen, a biopharmaceutical company, aims to develop cancer-selective gene therapy products to fight cancer by increasing the lifespan of patients with advanced local and metastatic cancer. Their products will activate a patient's immune system against their cancer, generating a broadly applicable cure for the disease.

Annual Reports

Frequently Asked Questions

What is Tocagen's ticker?

Tocagen's ticker is TOCA

What exchange is Tocagen traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Tocagen's headquarters?

They are based in San Diego, California

How many employees does Tocagen have?

There are 51-200 employees working at Tocagen

What is Tocagen's website?

It is https://tocagen.com/

What type of sector is Tocagen?

Tocagen is in the Healthcare sector

What type of industry is Tocagen?

Tocagen is in the Biotechnology industry

Who are Tocagen's peers and competitors?

The following five companies are Tocagen's industry peers:

- OKYO Pharma Limited

- GENFIT S.A.

- SIGA

- Xbiotech Inc

- Affimed